| Device |
transcatheter septal occluder (atrial) |
| Definition |
For the treatment of defects in the atrial septum and closure of atrial septal defects via transcatheter technique. |
| Physical State |
permanent implant placed in septum (usually constructed of a combination of metals/polymers that is placed via a venous catheter system) |
| Technical Method |
percutaneous venous puncture and interventional technique |
| Target Area |
cardiac atrial septum |
| Review Panel |
Cardiovascular |
| Product Code | OZG |
| Premarket Review |
Office of Cardiovascular Devices
(OHT2)
Circulatory Support, Structural and Vascular Devices
(DHT2B)
|
| Submission Type |
PMA
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
Yes
|
| Life-Sustain/Support Device? |
No
|
| Recognized Consensus Standard
|
| Third Party Review |
Not Third Party Eligible |